Halozyme Therapeutics, Inc. (HALO)
63.08
-1.41
(-2.19%)
USD |
NASDAQ |
Apr 06, 16:00
63.09
+0.01
(+0.02%)
After-Hours: 20:00
Halozyme Therapeutics Price : 63.08 for April 6, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Skye Bioscience, Inc. | 0.7085 |
| Johnson & Johnson | 240.97 |
| Eli Lilly & Co. | 927.06 |
| Stryker Corp. | 332.30 |
| Glaukos Corp. | 116.69 |
Price Related Metrics
| PE Ratio | 24.77 |
| PS Ratio | 5.422 |
| Price to Book Value | 149.20 |
| Price to Free Cash Flow | 11.75 |
| Earnings Yield | 4.04% |
| Market Cap | 7.283B |
| Operating PE Ratio | 9.276 |
| Normalized PE Ratio | 13.44 |